TUMOR, SOLID
Clinical trials for TUMOR, SOLID explained in plain language.
Never miss a new study
Get alerted when new TUMOR, SOLID trials appear
Sign up with your email to follow new studies for TUMOR, SOLID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer combo trial halted early: what we know
Disease control TerminatedThis phase 2 trial tested two drugs—ulixertinib and hydroxychloroquine—in 47 people with advanced gastrointestinal cancers that have certain genetic mutations (MAPK pathway). The goal was to see if the combination could shrink tumors. However, the study was terminated early, so t…
Matched conditions: TUMOR, SOLID
Phase: PHASE2 • Sponsor: BioMed Valley Discoveries, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Personalized cancer vaccine trial halted early – what we know
Disease control TerminatedThis phase 2 trial tested a personalized cancer vaccine called TLPO in 63 people with various solid tumors. The vaccine was made from a patient's own tumor material to train their immune system to fight the cancer. The study aimed to see if the vaccine could delay disease progres…
Matched conditions: TUMOR, SOLID
Phase: PHASE2 • Sponsor: Elios Therapeutics, LLC • Aim: Disease control
Last updated Jun 26, 2026 16:56 UTC